348 related articles for article (PubMed ID: 2881873)
41. The utility of cytokeratin subsets in distinguishing Barrett's-related oesophageal adenocarcinoma from gastric adenocarcinoma.
Ormsby AH; Goldblum JR; Rice TW; Richter JE; Gramlich TL
Histopathology; 2001 Apr; 38(4):307-11. PubMed ID: 11318895
[TBL] [Abstract][Full Text] [Related]
42. Carcinoma with multidirectional differentiation arising in Barrett's esophagus.
Banner BF; Memoli VA; Warren WH; Gould VE
Ultrastruct Pathol; 1983; 4(2-3):205-17. PubMed ID: 6136108
[TBL] [Abstract][Full Text] [Related]
43. Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviour.
Bibeau F; Chateau MC; Guiu M; Assenat E; Azria D; Lavaill R; Ychou M; Boissière-Michot F
Virchows Arch; 2008 Jan; 452(1):103-7. PubMed ID: 18008084
[TBL] [Abstract][Full Text] [Related]
44. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
Soslow RA; Remotti H; Baergen RN; Altorki NK
Mod Pathol; 1999 Mar; 12(3):239-50. PubMed ID: 10102608
[TBL] [Abstract][Full Text] [Related]
45. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
46. Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.
Levine DS; Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
Gastroenterology; 1989 Feb; 96(2 Pt 1):355-67. PubMed ID: 2910757
[TBL] [Abstract][Full Text] [Related]
47. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
48. [Histochemical diagnosis of short segment Barrett's esophagus].
Fujiyama Y; Ishizuka I; Koyama S
Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
[TBL] [Abstract][Full Text] [Related]
49. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence.
Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041
[TBL] [Abstract][Full Text] [Related]
50. Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia.
Kalish RJ; Clancy PE; Orringer MB; Appelman HD
Gastroenterology; 1984 Mar; 86(3):461-7. PubMed ID: 6693012
[TBL] [Abstract][Full Text] [Related]
51. Pancreatic metaplasia in Barrett's esophagus. An immunohistochemical study.
Krishnamurthy S; Dayal Y
Am J Surg Pathol; 1995 Oct; 19(10):1172-80. PubMed ID: 7573675
[TBL] [Abstract][Full Text] [Related]
52. Dysplasia in Barrett's esophagus.
Schmidt HG; Riddell RH; Walther B; Skinner DB; Riemann JF
J Cancer Res Clin Oncol; 1985; 110(2):145-52. PubMed ID: 4044629
[TBL] [Abstract][Full Text] [Related]
53. Activation of Wnt signalling promotes development of dysplasia in Barrett's oesophagus.
Moyes LH; McEwan H; Radulescu S; Pawlikowski J; Lamm CG; Nixon C; Sansom OJ; Going JJ; Fullarton GM; Adams PD
J Pathol; 2012 Sep; 228(1):99-112. PubMed ID: 22653845
[TBL] [Abstract][Full Text] [Related]
54. Distinct immunohistochemical findings in columnar epithelium of esophageal inlet patch and of Barrett's esophagus.
Feurle GE; Helmstaedter V; Buehring A; Bettendorf U; Eckardt VF
Dig Dis Sci; 1990 Jan; 35(1):86-92. PubMed ID: 2295298
[TBL] [Abstract][Full Text] [Related]
55. Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies.
Lewis CJ; Thrumurthy SG; Pritchard S; Armstrong G; Attwood SE
Surg Endosc; 2011 Aug; 25(8):2564-9. PubMed ID: 21359892
[TBL] [Abstract][Full Text] [Related]
56. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
Levine DS; Rubin CE; Reid BJ; Haggitt RC
Lab Invest; 1989 Mar; 60(3):418-32. PubMed ID: 2927081
[TBL] [Abstract][Full Text] [Related]
57. The prevalence of gastric heterotopia of the proximal esophagus is underestimated, but preneoplasia is rare - correlation with Barrett's esophagus.
Peitz U; Vieth M; Evert M; Arand J; Roessner A; Malfertheiner P
BMC Gastroenterol; 2017 Jul; 17(1):87. PubMed ID: 28701149
[TBL] [Abstract][Full Text] [Related]
58. Expression of CD44 in premalignant and malignant Barrett's oesophagus.
Lagorce-Pages C; Paraf F; Dubois S; Belghiti J; Fléjou JF
Histopathology; 1998 Jan; 32(1):7-14. PubMed ID: 9522210
[TBL] [Abstract][Full Text] [Related]
59. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence.
Hardwick RH; Shepherd NA; Moorghen M; Newcomb PV; Alderson D
Gut; 1994 Jun; 35(6):764-8. PubMed ID: 8020801
[TBL] [Abstract][Full Text] [Related]
60. Barrett's oesophagus: Current controversies.
Amadi C; Gatenby P
World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
